Scipher Medicine Corp — Form D/A
Scipher Medicine Corp of WALTHAM, MA, a company, filed a Form D amendment with the SEC on 2021-03-31. The offering totals $82.0M, of which $82.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-31
- Form: D/A
- Accession: 0001104659-21-044668
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $82.0M
- Amount sold: $82.0M
- Minimum investment: $80K
- Investors: 12
- Date of first sale: 2021-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-393626
Issuer
- Name: Scipher Medicine Corp
- CIK: 0001658821
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 500 TOTTEN POND ROAD, 6TH FLOOR, WALTHAM, MA, 02451
- Phone: 781-755-2060
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Albert Laszlo Barabasi | Director | Waltham, MA |
| Michael Rubin | Director | Richmond Hill, A6 |
| Alif Saleh | Director | Metairie, LA |
| Jeffrey Sachs | Executive Officer | Mountain View, CA |
| Alif Saleh | Executive Officer | Metairie, LA |
| Samir Kaul | Director | San Francisco, CA |
| Miklos Kobor | Director | Metairie, LA |
| Alif Saleh | Promoter | Metairie, LA |
| Tim Anderson | Director | South San Francisco, CA |
| JOSEPH LOSCALZO | Director | WALTHAM, MA |
| REGINALD SEETO | Director | WALTHAM, MA |
| REGINALD SEETO | Executive Officer | WALTHAM, MA |
| INGO CHAKRAVARTY | Director | WALTHAM, MA |
| GLENN MUIR | Director | WALTHAM, MA |
| ALBERT-LASZLO BARABASI | Director | WALTHAM, MA |
| TODD SONE | Director | WALTHAM, MA |
| Peter Ruppert | Director | Boston, MA |
| Byron Kalogerou | Executive Officer | Waltham, MA |
| Albert Laszlo Barabsi | Director | Boston, MA |
| Marcell Veidner | Director | Boston, MA |
| Marcell Veidner | Executive Officer | Boston, MA |
| Marcell Veidner | Promoter | Boston, MA |
| Peter Laszlo Ruppert | Director | Boston, MA |
Other filings by this issuer (8)
More